Olefin Metathesis at the Dawn of Implementation in Pharmaceutical and Specialty-Chemicals Manufacturing

Angewandte Chemie - International Edition

Volumn 55, Issue 11, 2016, Pages 3552-3565

  Higman, Carolyn S ^a   Lummiss, Justin A M ^a   Fogg, Deryn E ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

industrial chemistry; large scale synthesis; olefin metathesis; pharmaceutical chemistry; renewable feedstocks

Indexed keywords

MANUFACTURE;

INDUSTRIAL CHEMISTRY; LARGE SCALE SYNTHESIS; OLEFIN METATHESIS; PHARMACEUTICAL CHEMISTRY; RENEWABLE FEEDSTOCKS;

OLEFINS;

EID: 84976251287     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201506846     Document Type: Review

References (77)

1. Leading Reviews of metathesis in natural products synthesis, including total synthesis:
2. A. Fürstner, Chem. Commun. 2011, 47, 6505-6511;
3. J. Cossy, S. Arseniyadis, C. Meyer, Metathesis in Natural Product Synthesis: Strategies, Substrates and Catalysts, Wiley-VCH, Weinheim, 2010;
4. W. H. C. Martin, S. Blechert, Curr. Top. Med. Chem. 2005, 5, 1521-1540;
5. K. C. Nicolaou, P. G. Bulger, D. Sarlah, Angew. Chem. Int. Ed. 2005, 44, 4490-4527;
6. Angew. Chem. 2005, 117, 4564-4601. For a recent overview of RCM, including advances toward metathesis of directly functionalized olefins, see:
7. B. J. van Lierop, J. A. M. Lummiss, D. E. Fogg, in Olefin Metathesis-Theory and Practice (Ed.:, K. Grela,), Wiley, Hoboken, 2014, pp. 85-152.
8. S. Chikkali, S. Mecking, Angew. Chem. Int. Ed. 2012, 51, 5802-5808;
9. Angew. Chem. 2012, 124, 5902-5909, and refs. therein.
10. U. Biermann, U. Bornscheuer, M. A. R. Meier, J. O. Metzger, H. J. Schafer, Angew. Chem. Int. Ed. 2011, 50, 3854-3871;
11. Angew. Chem. 2011, 123, 3938-3956.
12. K. Grela, Olefin Metathesis-Theory and Practice, Wiley, Hoboken, 2014.
13. S. Werrel, J. C. L. Walker, T. J. Donohoe, Tetrahedron Lett. 2015, 56, 5261-5268.
14. XiMo press release: "XiMo and Aspira Scientific Launch Air-Stable Metathesis Pills." October 13, 2015.
15. Elevance press release: "Elevance Renewable Sciences, XiMo AG Announce Significant Advancements in Technology for Metathesizing Natural Oils". April 10, 2012.
16. Versalis press release: "Versalis and Elevance Partner in Green Innovation for Premium Applications." February 6, 2014.
17. Elevance Renewable Sciences, Inc., Form S-1 Registration Statement. Filed with the United States Securities and Exchange Commission, Sept. 20, 2011.
18. Evonik Industries press release: "Elevance Renewable Sciences and Evonik Announce Metathesis Catalysts License Agreement." July 6, 2010.
19. S. A. Cohen, D. R. Anderson, Z. Wang, T. M. Champagne, T. A. Ung, (Elevance Renewable Sciences), US20140275681A1, 2014.
20. C. Lübbe, A. Dumrath, H. Neumann, M. Schäffer, R. Zimmermann, M. Beller, R. Kadyrov, ChemCatChem 2014, 6, 684-688.
21. T. Nicola, M. Brenner, K. Donsbach, P. Kreye, Org. Process Res. Dev. 2005, 9, 513-515.
22. H. Wang, S. N. Goodman, Q. Dai, G. W. Stockdale, W. M. Clark, Org. Process Res. Dev. 2008, 12, 226-234.
23. V. Farina, A. Horváth, in Handbook of Metathesis, 2nd. Ed., Vol. 2, Wiley-VCH, Weinheim, 2015, pp. 633-658.
24. L. A. Kunz, T. M. Pals, S. A. Cohen, M. L. Luetkens, Jr., C. Balakrishnan, R. B. Snyder, (Elevance Renewable Sciences), US20130217906A1, 2013.
25. S. A. Cohen, M. L. Luetkens, C. Balakrishnan, R. Snyder, (Elevance Renewable Sciences), WO2011046872A2, 2011.
26. K. R. Fandrick, J. Savoie, N. Y. Jinhua, J. J. Song, C. H. Senanayake, in Olefin Metathesis-Theory and Practice (Ed.:, K. Grela,), Wiley, Hoboken, 2014, pp. 349-366.
27. Å. Rosenquist, et al., J. Med. Chem. 2014, 57, 1673-1693.
28. D. Niu, D. Liu, J. D. Moore, G. Xu, Y. Sun, Y. Gai, D. Tang, Y. S. Or, Z. Wang, (Enanta Pharmaceuticals), US20090005387A1, 2009.
29. J. Kong, C.-Y. Chen, J. Balsells-Padros, Y. Cao, R. F. Dunn, S. J. Dolman, J. Janey, H. Li, M. J. Zacuto, J. Org. Chem. 2012, 77, 3820-3828.
30. H. Li, et al., Org. Lett. 2015, 17, 1533-1536.
31. J. Arumugasamy, et al., Org. Process Res. Dev. 2013, 17, 811-828.
32. Y. Jiang, et al., J. Med. Chem. 2014, 57, 1753-1769.
33. K. Puentener, M. Scalone, (La Roche), US7939668B2, 2011.
34. A. Poulsen, A. D. William, B. W. Dymock, in Macrocycles in Drug Discovery (Ed.:, J. Levin,), Royal Society of Chemistry, Cambridge, 2014, pp. 141-205.
35. A. D. William, A. C.-H. Lee, Chimia 2014, 142-145.
36. H. Wang, H. Matsuhashi, B. D. Doan, S. N. Goodman, X. Ouyang, W. M. Clark, Tetrahedron 2009, 65, 6291-6303.
37. Aileron Therapeutics press release: "Aileron Therapeutics Initiates Phase 1 Cancer Study of ALRN-6924 in Advanced Hematologic and Solid Malignancies with Wild Type p53." February 12, 2015.
38. B. Fidler, "Pharmas, Others Bet 33 m More on Aileron's P53 Peptide Drug", in Xconomy, Boston USA, Oct. 29 2014. http://www.xconomy.com/boston/2014/10/29/pharmas-others-bet-33m-more-on-ailerons-p53-peptide-drug, accessed July 21, 2015.
39. R. Schiess, K.-H. Altmann, in Macrocycles in Drug Discovery (Ed.:, J. Levin,), RSC, Cambridge, 2014, pp. 78-108.
40. H. R. Hoveyda, et al., J. Med. Chem. 2011, 54, 8305-8320.
41. J. Kuethe, Y.-L. Zhong, N. Yasuda, G. Beutner, K. Linn, M. Kim, B. Marcune, S. D. Dreher, G. Humphrey, T. Pei, Org. Lett. 2013, 15, 4174-4177.
42. H.-J. Federsel, Green Chem. 2013, 15, 3105-3115.
43. S. Monfette, D. E. Fogg, Chem. Rev. 2009, 109, 3783-3816.
44. For an overview of these and other direct-acting antivirals and a prospective view of their ultimate clinical applications, see:, E. De Clercq, Biochem. Pharmacol. 2014, 89, 441-452.
45. N. K. Yee, et al., J. Org. Chem. 2006, 71, 7133-7145.
46. V. Farina, C. Shu, X. Zeng, X. Wei, Z. Han, N. K. Yee, C. H. Senanayake, Org. Process Res. Dev. 2009, 13, 250-254.
47. X. Wei, et al., Org. Lett. 2013, 15, 1016-1019.
48. For an overview of relevant patents, current through early 2014, see: World Health Organization working paper, "Patent Situation of Key Products for Treatment of Hepatitis C." Prepared for the WHO by Thomson Reuters, Aug. 2014;
49. Simeprevir: http://www.who.int/phi/implementation/ip trade/simeprevir-report-2014-09-02.pdf?ua=1;
50. ABT-450: http://www.who.int/phi/implementation/ip-trade/ABT-450-report-2014-09-02.pdf?ua=1.
51. A. Horvath, S. Wuyts, D. P. M. Depré, W. L. J. Couck, J. L. J. Cuypers, S. Harutyunyan, G. F. S. Binot, (Janssen Pharmaceuticals), US2015/0152098 A1, 2015.
52. Enanta Pharmaceutical. Annual Report. Filed with the United States Security and Exchange Commission, 2014.
53. Y. Ku, et al., (Enanta Pharmaceuticals; Abbott Laboratories), WO2010030359A2, 2010.
54. J. A. M. Lummiss, B. J. Ireland, J. M. Sommers, D. E. Fogg, ChemCatChem 2014, 6, 459-463. For the mechanism by which amines and other Brønsted bases decompose HII, see:
55. B. J. Ireland, B. T. Dobigny, D. E. Fogg, ACS Catal. 2015, 5, 4690-4698.
56. Aileron Therapeutics, Safety Study of ALRN-6924 in Patients With Advanced Solid Tumors; Trial Number NCT02264613, U.S. National Institutes of Health, http://clinicaltrials.gov, 2015.
57. C. E. Garrett, K. Prasad, Adv. Synth. Catal. 2004, 346, 889-900.
58. A. M. Faucher, et al., Org. Lett. 2004, 6, 2901-2904.
59. G. C. Vougioukalakis, Chem. Eur. J. 2012, 18, 8868-8880.
60. C. Ong, J. M. Mueller, (Lanxess), WO2011023674A1, 2011.
61. US Department of Agriculture, Oil Crops Yearbook (Online), Table 47, accessed July 21, 2015. http://www.ers.usda.gov/data-products/oil-crops-yearbook.aspx.
62. Food Fats and Oils; Institute of Shortening and Edible Oils: Washington, USA, 2006.
63. Elevance press release: "Elevance Selects URS Corporation for Engineering, Procurement and Construction Services to Continue Advancing Natchez Biorefinery." February 5, 2014.
64. Elevance press release: "Elevance and Genting Enter New Biorefinery Collaboration." July 14, 2014.
65. A. Nickel, et al., Top. Catal. 2012, 55, 518-523.
66. K. A. Burdett, L. D. Harris, P. Margl, B. R. Maughon, T. Mokhtar-Zadeh, P. C. Saucier, E. P. Wasserman, Organometallics 2004, 23, 2027-2047.
67. A. K. Patel, et al., (Elevance Renewable Sciences), US 2015/0119602 Al, 2015.
68. D. L. Stern, A. A. Galuska, M. M. Wu, K. Wang, (ExxonMobil), US8772562B2, 2014.
69. K. O'Leary Havelka, G. E. Gerhardt, in Green Polymer Chemistry: Biobased Materials and Biocatalysis, American Chemical Society, Washington, DC, 2015, pp. 201-222.
70. D. R. Allen, et al., (Stepan), WO2012061098A1, 2012.
71. T. A. Murphy, M. A. Tupy, T. W. Abraham, A. Shafer, (Cargill), US20090217568 A1, 2009.
72. M. Mujkic, D. Cade, C. W. Lee, M. S. Starch, B. J. Swanton, (Elevance Renewable Sciences), WO2012006324A1, 2012.
73. R. L. Pederson, A. Nickel, in Olefin Metathesis-Theory and Practice (Ed.:, K. Grela,), Wiley, Hoboken, 2014, pp. 335-348.
74. S. C. Marinescu, R. R. Schrock, P. Muller, A. H. Hoveyda, J. Am. Chem. Soc. 2009, 131, 10840-10841.
75. R. M. Thomas, B. K. Keitz, T. M. Champagne, R. H. Grubbs, J. Am. Chem. Soc. 2011, 133, 7490-7496.
76. B. G. Harvey, H. A. Meylemans, R. L. Quintana, (United States Navy), US20150011807A1, 2015.
77. M. L. Luetkens, S. A. Cohen, C. Balakrishnan, (Elevance Renewable Sciences), WO2010062958A1, 2010.